- Report
- February 2024
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- January 2021
- 38 Pages
Global
€1200EUR$1,318USD£1,028GBP
- Book
- April 2018
- 224 Pages
- Book
- December 2018
North America
Gout is a form of arthritis caused by the buildup of uric acid in the body. It is a common condition in the field of Allergy and Immunology, and is often treated with medications such as non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. Other treatments may include lifestyle changes, such as reducing alcohol consumption and maintaining a healthy weight.
The Gout market is a growing segment of the Allergy and Immunology industry, with a focus on developing new treatments and therapies to improve patient outcomes. Companies in the market are researching new drugs and therapies to reduce the symptoms of gout, as well as developing diagnostic tools to help identify the condition.
Companies in the Gout market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more